NFKB1 and neoplasm: NFκB activation promotes not only inflammation [22] but tumour proliferation [23], cell death evasion [24], angiogenesis, metastasis [25] and inflammation-based mechanisms of drug resistance [26,27], as illustrated in Fig. 1.